SynAct Pharma
Phase 1SynAct Pharma is a clinical stage biotechnology company developing new innovative medicines with the ability to induce resolution of inflammation.
Founded
2014
Focus
Small Molecules
About
SynAct Pharma is a clinical stage biotechnology company developing new innovative medicines with the ability to induce resolution of inflammation.
Funding History
3Total raised: $33.5M
IPO$15MUndisclosedMar 15, 2021
Series B$12MIndustrifondenSep 15, 2020
Series A$6.5MIndustrifondenJun 15, 2018
Company Info
TypePrivate
Founded2014
LocationLund, Sweden
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile